About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
Logout
Obstetrics and Gynegology2025№7
The impact of abortions on...

The impact of abortions on women’s health

DOI
https://dx.doi.org/10.18565/aig.2025.129

Dolgushina N.V., Ermakova D.M., Sheshko E.L.

1) Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, Moscow, Russia; 2) Federal Service for Surveillance in Healthcare, Moscow, Russia

The objective of the review was to systematize the literature data on the impact of abortions on women’s health. The paper provides the conclusions that abortions have many negative effects; they cause both early and long-term complications, increasing the risks of gynecological and somatic diseases, obstetric and perinatal complications in subsequent pregnancies. Early pregnancy complications include bleeding, uterine perforation, amniotic fluid embolism, thromboembolic, infectious and inflammatory complications. The long-term consequences of abortions refer to gynecological diseases, infertility, obstetric complications in subsequent pregnancies (gestational diabetes, placenta previa, cervical incompetence, premature birth, bleeding, low birth weight), oncological and cardiovascular diseases, and mental health disorders. Measures aimed at preventing abortions and supporting women in their reproductive choices are important steps to protect women’s general and reproductive health, and as a result, improve the demographic situation.
Conclusion: In recent years, a large number of measures have been taken in the Russian Federation to reduce the number of induced abortions. Clinical guidelines and standards have been approved, and interactive educational modules on psychological pre-abortion counseling have been implemented. Speech modules for communicating with women in situations of reproductive choice have also been introduced into the work of medical organizations. Motivational surveys are conducted as part of a program to provide individual recommendations and support measures for women in such situations.

Authors’ contributions: Dolgushina N.V., Ermakova D.M., Sheshko E.L. – developing the concept and design of the study, collecting and processing the material, writing the text, editing.
Conflicts of interest: Authors declare lack of the possible conflicts of interest.
Funding: The study was conducted without sponsorship.
For citation: Dolgushina N.V., Ermakova D.M., Sheshko E.L. The impact of abortions on women’s health.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (7): 5-11 (in Russian)
https://dx.doi.org/10.18565/aig.2025.129

Keywords

abortions
early complications
late complications
women’s reproductive health
prevention
Full text (in Russian)

References

  1. Bearak J., Popinchalk A., Ganatra B., Moller A.-B., Tunçalp Ö., Beavin C. et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. Lancet Glob. Heal. 2020; 8(9): e1152-61. https://dx.doi.org/10.1016/S2214-109X(20)30315-6
  2. Bridwell R.E., Long B., Montrief T., Gottlieb M. Post-abortion complications: a narrative review for emergency clinicians. West. J. Emerg. Med. 2022; 23(6): 919-25. https://dx.doi.org/10.5811/westjem.2022.8.57929
  3. Kerns J.L., Brown K., Nippita S., Steinauer J. Society of Family Planning Clinical Recommendation: Management of hemorrhage at the time of abortion. Contraception. 2024; 129: 110292. https://dx.doi.org/10.1016/j.contraception.2023.110292
  4. Choudhary N., Saha S.C., Gopalan S. Abortion procedures in a tertiary care institution in India. Int. J. Gynaecol. Obstet. 2005; 91(1): 81-6. https://dx.doi.org/10.1016/j.ijgo.2005.06.012
  5. Frick A.C., Drey E.A., Diedrich J.T., Steinauer J.E. Effect of prior cesarean delivery on risk of second-trimester surgical abortion complications. Obstet. Gynecol. 2010; 115(4): 760-4. https://dx.doi.org/10.1097/AOG.0b013e3181d43f42
  6. ACOG Practice Bulletin No. 135: Second-Trimester Abortion. Obstet. Gynecol. 2013; 121(6): 1394-1406. https://dx.doi.org/10.1097/01.AOG.0000431056.79334.cc
  7. Ashok P.W., Templeton A., Wagaarachchi P.T., Flett G.M.M. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 2004; 69(1): 51-8. https://dx.doi.org/10.1016/j.contraception.2003.09.006
  8. Goyal V. Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: a systematic review. Obstet. Gynecol. 2009; 113(5): 1117-23. https://dx.doi.org/10.1097/AOG.0b013e31819dbfe2
  9. White K., Carroll E., Grossman D. Complications from first-trimester aspiration abortion: a systematic review of the literature. Contraception. 2015; 92(5): 422-38. https://dx.doi.org/10.1016/j.contraception.2015.07.013
  10. Premkumar A., Huysman B., Cheng C., Einerson B.D., Moayedi G. Placenta accreta spectrum in the second trimester: a clinical conundrum in procedural abortion care. Am. J. Obstet. Gynecol. 2025; 232(1): 92-101. https://dx.doi.org/10.1016/j.ajog.2024.07.045
  11. Benson M.D. Amniotic fluid embolism mortality rate. J. Obstet. Gynaecol. Res. 2017; 43(11): 1714-8. https://dx.doi.org/10.1111/jog.13445
  12. Creanga A.A., Syverson C., Seed K., Callaghan W.M. Pregnancy-related mortality in the United States, 2011–2013. Obstet. Gynecol. 2017; 130(2): 366-73. https://dx.doi.org/10.1097/AOG.0000000000002114
  13. Niinimäki M., Pouta A., Bloigu A., Gissler M., Hemminki E., Suhonen S., Heikinheimo O. Immediate complications after medical compared with surgical termination of pregnancy. Obstet. Gynecol. 2009; 114(4): 795-804. https://dx.doi.org/10.1097/AOG.0b013e3181b5ccf9
  14. World Health Organization. Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008. 6th ed. 2011. 57 p.
  15. Patel A., Talmont E., Morfesis J., Pelta M., Gatter M., Momtaz M.R. et al. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception. 2006; 73(4): 420-30. https://dx.doi.org/10.1016/j.contraception.2005.10.004
  16. Parazzini F., Mais V., Cipriani S., Busacca M., Venturini P. Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009; 143(2): 103-6. https://dx.doi.org/10.1016/j.ejogrb.2008.12.010
  17. Pun S. Induced abortion: a risk factor for adenomyosis. J. Nepal Health Res. Counc. 2023; 20(4): 913-5. https://dx.doi.org/10.33314/jnhrc.v20i4.4649
  18. Shrestha A. Risk factors for adenomyosis. J. Nepal Health Res. Counc. 2012; 10(22): 229-33.
  19. Genc M., Genc B., Cengiz H. Adenomyosis and accompanying gynecological pathologies. Arch. Gynecol. Obstet. 2015; 291(4): 877-81. https://dx.doi.org/10.1007/s00404-014-3498-8
  20. Kobayashi H., Matsubara S., Imanaka S. Clinicopathological features of different subtypes in adenomyosis: focus on early lesions. PLOS One. 2021; 16(7): e0254147. https://dx.doi.org/10.1371/journal.pone.0254147
  21. Grimes D.A., Benson J., Singh S., Romero M., Ganatra B., Okonofua F.E., Shah I.H. Unsafe abortion: the preventable pandemic. Lancet. 2006; 368(9550): 1908-19. https://dx.doi.org/10.1016/S0140-6736(06)69481-6
  22. Чучалина Л.Ю. Роль искусственного прерывания беременности в первом триместре в формировании вторичного бесплодия. Акушерство и гинекология. 2016; 11: 113-6. [Chuchalina L.Yu. The role of induced abortion in the first trimester of pregnancy in the development of secondary infertility. Obstetrics and Gynecology. 2016; (11): 113-6 (in Russian)]. https://dx.doi.org/10.18565/aig.2016.11.113-6
  23. Wang H., Guo X., Song Q., Su W., Meng M., Sun C. et al. Association between the history of abortion and gestational diabetes mellitus: a meta-analysis. Endocrine. 2023; 80(1): 29-39. https://dx.doi.org/10.1007/s12020-022-03246-x
  24. Zhang J., Savitz D.A. Maternal age and placenta previa: a population-based, case-control study. Am. J. Obstet. Gynecol. 1993; 168(2): 641-5. https://dx.doi.org/10.1016/0002-9378(93)90511-G
  25. Faiz A.S., Ananth C.V. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J. Matern. Fetal Neonatal. Med. 2003; 13(3): 175-90. https://dx.doi.org/10.1080/jmf.13.3.175.190
  26. Hung T.H., Hsieh C.C., Hsu J.J., Chiu T.H., Lo L.M., Hsieh T.T. Risk factors for placenta previa in an Asian population. Int. J. Gynaecol. Obstet 2007; 97(1): 26-30. https://dx.doi.org/10.1016/j.ijgo.2006.12.006
  27. Johnson L.G., Mueller B.A., Daling J.R. The relationship of placenta previa and history of induced abortion. Int. J. Gynaecol. Obstet. 2003; 81(2): 191-8. https://dx.doi.org/10.1016/s0020-7292(03)00004-3
  28. Zhu Q.X., Gao E.S., Chen A.M., Luo L., Cheng Y.M., Yuan W. Mifepristone-induced abortion and placental complications in subsequent pregnancy. Hum. Reprod. 2009; 24(2): 315-9. https://dx.doi.org/10.1093/humrep/den426
  29. Koifman A., Levy A., Zaulan Y., Harlev A., Mazor M., Wiznitzer A., Sheiner E. The clinical significance of bleeding during the second trimester of pregnancy. Arch. Gynecol. Obstet. 2008; 278(1): 47-51. https://dx.doi.org/10.1007/s00404-007-0530-2
  30. Lowit A., Bhattacharya S., Bhattacharya S. Obstetric performance following an induced abortion. Best. Pract. Res. Clin. Obstet. Gynaecol. 2010; 24(5): 667-82. https://dx.doi.org/10.1016/j.bpobgyn.2010.02.015
  31. Shah P.S., Zao J. Induced termination of pregnancy and low birthweight and preterm birth: a systematic review and meta-analyses. BJOG. 2009; 116(11): 1425-42. https://dx.doi.org/10.1111/j.1471-0528.2009.02278.x
  32. Saccone G., Perriera L., Berghella V. Prior uterine evacuation of pregnancy as independent risk factor for preterm birth: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2016; 214(5): 572-91. https://dx.doi.org/10.1016/j.ajog.2015.12.044
  33. Lemmers M., Verschoor M.A.C., Hooker A.B., Opmeer B.C., Limpens J., Huirne J.A.F. et al. Dilatation and curettage increases the risk of subsequent preterm birth: a systematic review and meta-analysis. Hum. Reprod. 2016; 31(1): 34-45. https://dx.doi.org/10.1093/humrep/dev274
  34. Freak-Poli R., Chan A., Tucker G., Street J. Previous abortion and risk of pre-term birth: a population study. J. Matern. Fetal Neonatal Med. 2009; 22(1): 1-7. https://dx.doi.org/10.1080/14767050802531813
  35. Mitrogiannis I., Evangelou E., Efthymiou A., Kanavos T., Birbas E., Makrydimas G. et al. Risk factors for preterm birth: an umbrella review of meta-analyses of observational studies. BMC Med. 2023; 21(1): 494. https://dx.doi.org/10.1186/s12916-023-03171-4
  36. Brittain J.J., Wahl S.E., Strauss J.F., Romero R., Wolf H.M., Murphy K. et al. Prior spontaneous or induced abortion is a risk factor for cervical dysfunction in pregnant women: a systematic review and meta-analysis. Reprod. Sci. 2023; 30(7): 2025-39. https://dx.doi.org/10.1007/s43032-023-01170-7
  37. Kyriacou H., Al-Mohammad A., Muehlschlegel C., Foster-Davies L., Bruco M.E.F., Legard C. et al. The risk of cardiovascular diseases after miscarriage, stillbirth, and induced abortion: a systematic review and meta-analysis. Eur. Hear. J. Open. 2022; 2(5): oeac065. https://dx.doi.org/10.1093/ehjopen/oeac065
  38. Brind J., Chinchilli V.M., Severs W.B., Summy-Long J. Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis. J. Epidemiol. Community Health. 1996; 50(5): 481-96. https://dx.doi.org/10.1136/jech.50.5.481
  39. Islam M.A., Sathi N.J., Abdullah H.M., Tabassum T.A. Meta-analysis of induced abortion, alcohol consumption, and smoking triggering breast cancer risk among women from developed and least developed countries. Int. J. Clin. Pract. 2022; 2022: 6700688. https://dx.doi.org/10.1155/2022/6700688
  40. Brind J., Condly S.J., Lanfranchi A., Rooney B. Induced abortion as an independent risk factor for breast cancer: a systematic review and meta-analysis of studies on south asian women. Issues Law Med. 2018; 33(1): 32-54.
  41. Cuenca D. Pregnancy loss: Consequences for mental health. Front. Glob. Womens Health. 2022; 3: 1032212. https://dx.doi.org/10.3389/fgwh.2022.1032212
  42. Mergl R., Quaatz S.M., Edeler L.M., Allgaier A.K. Grief in women with previous miscarriage or stillbirth: a systematic review of cross-sectional and longitudinal prospective studies. Eur. J. Psychotraumatol. 2022; 13(2): 2108578. https://dx.doi.org/10.1080/20008066.2022.2108578
  43. Bellieni C.V., Buonocore G. Abortion and subsequent mental health: Review of the literature. Psychiatry Clin. Neurosci. 2013; 67(5): 301-10. https://dx.doi.org/10.1111/pcn.12067
  44. Coleman P.K. Abortion and mental health: quantitative synthesis and analysis of research published 1995–2009. Br. J. Psychiatry. 2011; 199(3): 180-6. https://dx.doi.org/10.1192/bjp.bp.110.077230
  45. Charles V.E., Polis C.B., Sridhara S.K., Blum R.W. Abortion and long-term mental health outcomes: a systematic review of the evidence. Contraception. 2008; 78(6): 436-50. https://dx.doi.org/10.1016/j.contraception.2008.07.005
  46. Gissler M., Karalis E., Ulander V.M. Decreased suicide rate after induced abortion, after the Current Care Guidelines in Finland 1987–2012. Scand. J. Public Health. 2015; 43(1): 99-101. https://dx.doi.org/10.1177/1403494814560844

Received 14.05.2025

Accepted 23.06.2025

About the Authors

Nataliya V. Dolgushina, Dr. Med. Sci., Professor, Deputy Director for Scientific Work, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4 Oparina str., Moscow, 117997, Russia, n_dolgushina@oparina4.ru, https://orcid.org/0000-0003-1116-138X
https://orcid.org/0000-0003-1116-138X
Daria M. Ermakova, PhD, Researcher, obstetrician-gynecologist, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4 Oparina str., Moscow, 117997, Russia, +7(906)555-79-97, daria.ermakova.97@bk.ru, https://orcid.org/0000-0002-8558-4687
Elena L. Sheshko, PhD, Deputy Head, Federal Service for Surveillance in Healthcare of the Russian Federation, Moscow, Russia.

Similar Articles

№8 / 2021
Shikh E.V., Makhova A.A., Prokofiev A.B., Nazarchuk A.S.
Vitamins and trace elements in the prevention of infectious diseases in women of reproductive age
№7 / 2022
Khryshchanovich V.Ya., Rogovoy N.A., Skobeleva N.Ya., Krasko O.V.
Efficiency of graduated compression for varicose veins during pregnancy
№11 / 2018
Tezikov Yu.V., Lipatov I.S., Pechkurov D.V.,Tyutyunnik V.L., Kan N.E., Protasov A.D., Kovyazina I.O.
Predicting impairment of pre–lactation transformation and preventing lactogenesis failure in metabolic syndrome
№10 / 2024
Sulima A.N., Rumyantseva Z.S., Nikolaeva E.I., Efremova N.V., Bakharovskaya A.S.
Asherman’s syndrome in patients of reproductive age
№1 / 2020
Gorodnova T.V., Sokolenko A.P., Kotiv Kh.B., Yakovleva M.G., Lavrinovich O.E., Mikaya N.A., Ibragimov Z.N., Trifanov Yu.N., Bondarev N.E., Nekrasova E.A., Sidoruk A.A., Smirnova O.A., Guseinov K.D., Bakhidze E.V., Meshkova I.E., Bakaeva E.Kh., Shikhzadaeva M.G., Ul’rikh E.A., Urmancheeva A.F., Berlev I.V., Imyanitov E.N., Belyaev A.M.
Prophylactic surgery in carriers of BRCA1 or BRCA2 gene mutation
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.